Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: Potential role of central adiposity and low-grade inflammation - The Hoorn Study

Thrombosis Research

Volumn 129, Issue 5, 2012, Pages 557-562

  Beijers, Hanneke J B H ^a   Ferreira, Isabel ^b,c   Spronk, Henri M H ^b,c   Bravenboer, Bert ^a   Dekker, Jacqueline M ^d   Nijpels, Giel ^d   Ten Cate, Hugo ^b,c   Stehouwer, Coen D A ^b,c  

^a CATHARINA HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Endogenous thrombin potential (ETP); Epidemiology; Thrombin generation; Type 2 diabetes

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; THROMBIN; THROMBOMODULIN;

AGED; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; DYSLIPIDEMIA; FEMALE; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SMOKING; THROMBOCYTE POOR PLASMA; WAIST CIRCUMFERENCE;

ADIPOSITY; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INFLAMMATION; MALE; OBESITY; RISK FACTORS; THROMBOPHILIA; WAIST CIRCUMFERENCE;

EID: 84860475403     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.07.033     Document Type: Article

References (43)

1. L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, and M.J. de Boer Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur Heart J 28 2007 88 136
2. J.A. Beckman, M.A. Creager, and P. Libby Diabetes and atherosclerosis: epidemiology, pathophysiology, and management Jama 287 2002 2570 2581
3. J.T. Crawley, S. Zanardelli, C.K. Chion, and D.A. Lane The central role of thrombin in hemostasis J Thromb Haemost 5 Suppl. 1 2007 95 101
4. D.A. Lane, H. Philippou, and J.A. Huntington Directing thrombin Blood 106 2005 2605 2612
5. G. Boden, V.R. Vaidyula, C. Homko, P. Cheung, and A.K. Rao Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose J Clin Endocrinol Metab 92 2007 4352 4358
6. E. Morishita, H. Asakura, H. Jokaji, M. Saito, C. Uotani, and I. Kumabashiri Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus Atherosclerosis 120 1996 7 14
7. T. Yamada, A. Sato, T. Nishimori, T. Mitsuhashi, A. Terao, and H. Sagai Importance of hypercoagulability over hyperglycemia for vascular complication in type 2 diabetes Diabetes Res Clin Pract 49 2000 23 31
8. J.J. van Veen, A. Gatt, and M. Makris Thrombin generation testing in routine clinical practice: are we there yet? Br J Haematol 142 2008 889 903
9. H.C. Hemker Al Dieri R, De Smedt E, Beguin S. Thrombin generation, a function test of the haemostatic-thrombotic system Thromb Haemost 96 2006 553 561
10. H.C. Hemker, P. Giesen, R. AlDieri, V. Regnault, E. de Smed, and R. Wagenvoord The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability Pathophysiol Haemost Thromb 32 2002 249 253
11. Y. Dargaud, M.C. Trzeciak, J.C. Bordet, J. Ninet, and C. Negrier Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype Thromb Haemost 96 2006 562 567
12. S.N. Tchaikovski, H.A. van Vliet, M.C. Thomassen, R.M. Bertina, F.R. Rosendaal, and P.M. Sandset Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography Thromb Haemost 98 2007 1350 1356
13. A.J. ten Cate-Hoek, A.W. Dielis, H.M. Spronk, R. van Oerle, K. Hamulyak, and M.H. Prins Thrombin generation in patients after acute deep-vein thrombosis Thromb Haemost 100 2008 240 245
14. T. Baglin The measurement and application of thrombin generation Br J Haematol 130 2005 653 661
15. A. Tripodi, A. Branchi, V. Chantarangkul, M. Clerici, G. Merati, and A. Artoni Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay J Thromb Thrombolysis 31 2011 165 172
16. H.J. Beijers, I. Ferreira, H.M. Spronk, B. Bravenboer, J.M. Dekker, and G. Nijpels Body Composition as Determinant of Thrombin Generation in Plasma: The Hoorn Study Arterioscler Thromb Vasc Biol 30 2010 2639 2647
17. C.C. Lee, A.I. Adler, M.S. Sandhu, S.J. Sharp, N.G. Forouhi, and S. Erqou Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis Diabetologia 52 2009 1040 1047
18. R.J. Bisoendial, J.J. Kastelein, J.H. Levels, J.J. Zwaginga, B. van den Bogaard, and P.H. Reitsma Activation of inflammation and coagulation after infusion of C-reactive protein in humans Circ Res 96 2005 714 716
19. F. de Vegt, J.M. Dekker, A. Jager, E. Hienkens, P.J. Kostense, and C.D. Stehouwer Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study JAMA 285 2001 2109 2113
20. J.M. Mooy, P.A. Grootenhuis, H. de Vries, H.A. Valkenburg, L.M. Bouter, and P.J. Kostense Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study Diabetes Care 18 1995 1270 1273
21. A.M. Spijkerman, M.C. Adriaanse, J.M. Dekker, G. Nijpels, C.D. Stehouwer, and L.M. Bouter Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile Diabetes Care 25 2002 1784 1789
22. World Health Organization Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva 1999
23. A.W. Dielis, E. Castoldi, H.M. Spronk, R. van Oerle, K. Hamulyak, and H. Ten Cate Coagulation factors and the protein C system as determinants of thrombin generation in a normal population J Thromb Haemost 6 2008 125 131
24. H.J. Beijers, I. Ferreira, B. Bravenboer, J.M. Dekker, G. Nijpels, and R.J. Heine Microalbuminuria and cardiovascular autonomic dysfunction are independently associated with cardiovascular mortality: evidence for distinct pathways: the Hoorn Study Diabetes Care 32 2009 1698 1703
25. P.J. Beks, A.J. Mackaay, J.N. de Neeling, H. de Vries, L.M. Bouter, and R.J. Heine Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study Diabetologia 38 1995 86 96
26. J.A. Whitworth 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension J Hypertens 21 2003 1983 1992
27. A. Jager, V.W. van Hinsbergh, P.J. Kostense, J.J. Emeis, J.S. Yudkin, and G. Nijpels von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study Arterioscler Thromb Vasc Biol 19 1999 3071 3078
28. A.B. Sobol, and C. Watala The role of platelets in diabetes-related vascular complications Diabetes Res Clin Pract 50 2000 1 16
29. M.C. Alessi, and I. Juhan-Vague PAI-1 and the metabolic syndrome: links, causes, and consequences Arterioscler Thromb Vasc Biol 26 2006 2200 2207
30. P.B. Leurs, R.P. Stolk, K. Hamulyak, R. Van Oerle, D.E. Grobbee, and B.H. Wolffenbuttel Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes Diabetes Care 25 2002 1340 1345
31. S.M. Haffner, M.P. Stern, H.P. Hazuda, B.D. Mitchell, and J.K. Patterson Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263 1990 2893 2898
32. E.A. El-Ghoroury, H.G. El-Din, M. Abdel-Kader, and S. Ragab Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus Blood Coagul Fibrinolysis 19 2008 7 13
33. T. Kokawa, T. Abumiya, T. Kimura, M. Harada-Shiba, H. Koh, and M. Tsushima Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein-associated and free forms in hyperlipidemia Arterioscler Thromb Vasc Biol 15 1995 504 510
34. P. Lesnik, A. Vonica, M. Guerin, M. Moreau, and M.J. Chapman Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a) Arterioscler Thromb 13 1993 1066 1075
35. J. Cermak, N.S. Key, R.R. Bach, J. Balla, H.S. Jacob, and G.M. Vercellotti C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor Blood 82 1993 513 520
36. E. Paffen, H.L. Vos, and R.M. Bertina C-reactive protein does not directly induce tissue factor in human monocytes Arterioscler Thromb Vasc Biol 24 2004 975 981
37. I. Aoki, K. Shimoyama, N. Aoki, M. Homori, A. Yanagisawa, and K. Nakahara Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes J Am Coll Cardiol 27 1996 560 566
38. J.I. Osende, J.J. Badimon, V. Fuster, P. Herson, P. Rabito, and R. Vidhun Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control J Am Coll Cardiol 38 2001 1307 1312
39. R. Demirtunc, D. Duman, M. Basar, M. Bilgi, M. Teomete, and T. Garip The relationship between glycemic control and platelet activity in type 2 diabetes mellitus J Diabetes Complications 23 2009 89 94
40. K. Krekora, D. De Lucia, F. Capani, M.B. Donati, and L. Iacoviello Association of coagulation factor VArg506Gln mutation with non-insulin-dependent diabetes mellitus Lancet 348 1996 1666 1667
41. L.M. Hart, R.P. Stolk, J.M. Dekker, G. Nijpels, D.E. Grobbee, and R.J. Heine Prevalence of variants in candidate genes for type 2 diabetes mellitus in The Netherlands: the Rotterdam study and the Hoorn study J Clin Endocrinol Metab 84 1999 1002 1006
42. R.E. Maser, M.E. Miele, M.J. Lenhard, G.S. Decherney, K.W. McNicholas, and A.J. Serra Lack of association of factor V Leiden and coronary heart disease in individuals with and without diabetes Diabetes Care 21 1998 198 199
43. S.F. Wakim-Ghorayeb, S.H. Keleshian, G. Timson, R.R. Finan, P. Najm, and N. Irani-Hakime Factor V G1691A (Leiden) and prothrombin G20210A single-nucleotide polymorphisms in type 2 diabetes mellitus Am J Hematol 80 2005 84 86